home All News open_in_new Full Article

Weight loss jabs do not slow Alzheimer's disease as hoped, causing firm's share prices to plummet

Novo Nordisk had hoped to repurpose semaglutide - the active ingredient in its Wegovy and Ozempic jabs - as a groundbreaking dementia treatment after seeing early encouraging signs.


today 17 h. ago attach_file Economics

attach_file Economics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Events
attach_file Economics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics


ID: 3285680034
Add Watch Country

arrow_drop_down